• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Human coagulation factor XIIIa expressed in pichia pastoris as fXIIIa hemostatic agent

Bioengineer by Bioengineer
July 28, 2020
in Chemistry
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

This article by Dr. Xu et al. is published in Protein & Peptide Letters, 2020

IMAGE

Credit: Dr. Xu et al., Bentham Science Publishers

Many reports illustrate that Coagulation factor XIIIa (FXIIIa) has diverse and crucial functions in thrombus for¬mation and stability. However, it is difficult to obtain large amounts of FXIII in the market. Therefore, obtaining large quantities of FXIIIa through genetic engineering technology is important for both clinical treatment and mechanism of protein expression.

The expression, purification and identification of recombinant human coagulation factor XIIIa in Pichia pastoris (a species of methylotrophic yeast) shows that it has biological activity, suggests a study conducted by a team of researchers at the Zhejiang Chinese Medical University led by Xu et al.

Recombinant pPICZαC-FXIIIa was expressed in Pichia pastoris, purified and then tested for biological activity by reacting it with plasma samples.

In this study, FXIIIa fragments in human placenta tissue was taken and inserted in an expression vector under the control of a yeast promoter for AOX1, which was constructed and expressed in Pichia pastoris (Figure 1). The findings suggest that the FXIIIa fragment of 2250 bp was inserted successfully into the pPICZαC vector. The expression and purification products about 83 kDa (the same molecular weight as human FXIIIa) were obtained, which solidified significantly when reacted with human plasma. The work shown that the expression and purification products were successful, with sufficient biological activity, which can be used as a candidate FXIIIa hemostatic agent in genetic engineering.

This study is significant as is reports an efficient expression system for the production of FXIIIa. This will not only facilitate further studies of FXIIIa, but also pave the way for possible large-scale production of biologically active FXIIIa. The researchers note that more work on recombinant FXIIIa production with higher purity and more activity would be investigated, to improve upon current results.

###

This article can be obtained from the following link: https://www.eurekaselect.com/node/183155/article/expression-purification-and-characterization-of-recombinant-human-coagulation-factor-xiiia-in-pichia-pastoris

Media Contact
Faizan ul Haq
[email protected]

Related Journal Article

http://dx.doi.org/10.2174/0929866527666200625203240

Tags: BiochemistryBioinformaticsBiologyBiomedical/Environmental/Chemical EngineeringBiotechnologyCell BiologyGenesGeneticsMolecular Biology
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Breakthrough in Environmental Cleanup: Scientists Develop Solar-Activated Biochar for Faster Remediation

February 7, 2026
blank

Cutting Costs: Making Hydrogen Fuel Cells More Affordable

February 6, 2026

Scientists Develop Hand-Held “Levitating” Time Crystals

February 6, 2026

Observing a Key Green-Energy Catalyst Dissolve Atom by Atom

February 6, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Evaluating Pediatric Emergency Care Quality in Ethiopia

TPMT Expression Predictions Linked to Azathioprine Side Effects

Improving Dementia Care with Enhanced Activity Kits

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.